YOLFTbeta
eXoZymes, Inc.

eXoZymes, Inc.

EXOZ · NASDAQ · Healthcare / Biotechnology

3.83USD-0.17 (-4.25%)

Price History

Full chart

Market Stats

Previous Close4.00
Open4.10
Day Range3.54 – 4.25
52-Week Range4.35 – 18.40
Volume20.05K
Market Cap58.80M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.20
Dividend Yield0.00%
50-Day Avg5.96
200-Day Avg8.74

About

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Michael Heltzen
  • Employees32
  • Headquarters750 Royal Oaks Drive, Monrovia, CA, United States, 91016, USA
  • Websitehttps://www.exozymes.com

Leadership

  • Mr. Michael HeltzenPresident & CEO · b. 1981
  • Dr. Tyler Korman Ph.D.Co-Founder & Chief Scientific Officer · b. 1979
  • Dr. Paul Opgenorth Ph.D.Co-Founder & Vice President of Development · b. 1983
  • Mr. James U. Bowie Ph.D.Founder & Independent Director · b. 1962
  • Mr. Fouad NawazVice President of Finance · b. 1986
  • Mr. Damien A. PerrimanChief Commercial Officer · b. 1977
  • Mr. Lasse H. GorlitzVice President of Communications
  • Mr. Michael BurnsExecutive Vice President of Energy Transition
  • Ms. Amy LunzerChief of Staff

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue00000
Cost of Revenue59.41K147.75K-267.38K-
Gross Profit-59.41K-147.75K--267.38K-
Operating Expense1.23M1.18M-5.66M-
Operating Income-1.29M-1.33M-1.80M-5.93M-9.72M
EBITDA-1.15M-1.18M-1.80M-5.59M-8.98M
Net Income-1.21M-1.40M-2.04M-5.86M-9.16M
R&D454.45K348.08K527.48K1.87M3.71M

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.35M2.69M3.56M13.03M5.97M
Total Liabilities1.15M1.31M3.94M2.61M2.57M
Total Equity1.20M1.37M-384.32K10.42M3.40M
Cash547.81K558.57K66.53K9.72M3.04M
Total Debt720.63K608.77K1.61M1.39M1.24M
Net Debt172.82K50.20K1.55M-8.33M-1.80M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.59M-1.26M-1.18M-8.51M-6.50M
Investing Cash Flow-312.25K-87.21K-311.17K-359.22K-150.22K
Financing Cash Flow2.31M1.36M1.00M18.52M-27.71K
Capital Expenditure422.59K185.98K288.71K396.45K169.92K
Free Cash Flow-2.01M-1.44M-1.47M-8.90M-6.67M
FCF to OCF126.63%114.79%124.45%104.66%102.61%

Earnings

Report DateMar 31, 2025May 12, 2025Aug 12, 2025Nov 13, 2025Dec 31, 2025Mar 31, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate--------
EPS Actual-0.24-0.22-0.28-0.27-0.32-0.28-0.33-
Surprise--------
Timing--------

Key Statistics & Ratios

Market Cap58.80M
Enterprise Value54.65M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book16.21
EPS-1.20
Book Value0.394
Revenue (TTM)-700
Gross Profit (TTM)-700
EBITDA-10.26M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-187.16%
Return on Assets-74.74%
Shares Outstanding9.28M
Shares Float7.17M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.34%
Insiders
65.98%
Retail / Other
32.68%

Top Institutional Holders

  • Davidson Kahn Capital Management, LLC
    25.00K0.27%
  • Vanguard Capital Management, LLC
    22.19K0.24%
  • Geode Capital Management, LLC
    21.89K0.24%
  • Vanguard Fiduciary Trust Co
    9.43K0.10%
  • BlackRock Inc
    6.80K0.07%
  • Tower Research Capital LLC
    1.32K0.01%
  • Morgan Stanley - Brokerage Accounts
    1.25K0.01%
  • Mercer Global Advisors Inc.
    2500.00%
  • UBS Group AG
    240.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    86.39K0.93%
  • Fidelity Extended Market Index
    11.79K0.13%
  • iShares Micro-Cap ETF
    9.11K0.10%
  • Fidelity Series Total Market Index
    2.94K0.03%
  • Fidelity Total Market Index
    2.02K0.02%
  • Fidelity Nasdaq Composite Index
    2.00K0.02%
  • 1290 VT Micro Cap K
    8100.01%